SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market activity and heightened community discourse driven by persistent acquisition rumors and notable institutional volume in after-hours trading. Traders are actively debating the stock's valuation relative to its rare disease pipeline, while observing unconventional trading patterns that have fueled speculation of a potential buyout.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors grapple with heightened market volatility driven by escalating geopolitical tensions and institutional debates over Bitcoin's long-term utility as a hedge. The community remains deeply divided, with bulls pointing to historical price cycles and potential regulatory breakthroughs like the Clarity Act, while bears are emphasizing downside risks linked to broader economic uncertainty and shifting institutional flow dynamics.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the Square and Cash App segments. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. It also includes Cash App Card, which is linked to customer stored balances that customers can use to pay for purchases or withdraw funds from an ATM. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Block Inc. is seeing significant investor attention following a massive workforce reduction and strategic pivot toward an AI-native operational model, which triggered a strong positive market reaction despite broader fintech sector volatility. The community is actively debating the long-term implications of these aggressive cost-cutting measures, weighing the boost to profitability against concerns over potential brand impact and the sustainability of AI-driven restructuring.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is capturing market attention as essential DeFi infrastructure, bolstered by a high-profile partnership with the U.S. Department of Commerce to provide macroeconomic data on-chain. Investors are actively discussing the project's institutional-grade data model, its revenue-generating potential through protocol buybacks, and its critical role in the expanding Real World Asset (RWA) narrative.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is under intense scrutiny as shareholders react to the termination of a material asset management agreement, fueling widespread debate over the company's long-term viability and crypto-treasury strategy. The community is heavily polarized, with vocal investors expressing extreme frustration over persistent share price dilution and underperformance while others remain optimistic, citing the company's significant Ethereum holdings and staking yield as a deep-value opportunity.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals (REGN) is currently seeing heightened trading activity as investors react to regulatory challenges at a third-party manufacturing facility, which has triggered delays for key products like Eylea HD. While sentiment remains divided due to these supply chain hurdles and competitive pressure in the ophthalmology space, the community is closely monitoring upcoming earnings and pipeline developments, with many bulls pointing to strong revenue growth from blockbusters like Dupixent and Libtayo as reasons for long-term optimism.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending due to intense volatility following a quarterly earnings report that featured a strong double beat on top and bottom lines but provided cautious forward revenue guidance. The community is actively debating whether the double-digit price decline is a baseless overreaction caused by market makers or a justified correction given the stock's high valuation and competitive concerns within the AI infrastructure sector.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is currently capturing significant attention as investors react to the company's $5.8 billion all-stock merger with Valaris, which positions the combined entity as a dominant force in offshore drilling. The stock is being buoyed by a tightening high-specification drillship market, rising day rates, and ongoing geopolitical tensions in the Middle East that keep energy supply security at the forefront of community discussions.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The DJIA is currently oscillating amidst a complex landscape of geopolitical tension, cooling energy prices, and mixed economic data that have investors scrutinizing the sustainability of recent market highs. Market participants remain focused on potential Fed policy shifts and the impact of upcoming earnings cycles, while community discussions continue to center on how prolonged global instability could influence corporate valuation multiples.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh the potential impact of looming pharmaceutical tariffs, which are pushing the company to increase its U.S. manufacturing footprint. Simultaneously, the community is actively debating the company's aggressive M&A strategy, particularly its focus on expanding oncology and T-cell engager therapy pipelines, while keeping a watchful eye on patent litigation risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evotec (EVO) to Release Quarterly Earnings on Wednesday

Evotec (NASDAQ:EVO) will be releasing its Q4 2025 earnings on Wednesday, April 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-8-evotec-se-stock-1...

Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - Here's Why

Evotec (NASDAQ:EVO) Sees Strong Trading Volume - Time to Buy...

Evotec (NASDAQ:EVO) Shares Gap Up - Still a Buy?

Evotec (NASDAQ:EVO) Shares Gap Up - Here's Why...

Evotec AG (NASDAQ:EVO) Receives Consensus Recommendation of "Hold" from Analysts

Evotec AG (NASDAQ:EVO - Get Free Report) has been assigned a consensus rating of "Hold" from the five analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have ass...

Evotec Unveils Horizon Plan, Targets EUR 75M Savings and Guides 2026 EBITDA to EUR 0 40M

Evotec (NASDAQ:EVO) used a March 10, 2026 webcast to outline Horizon, the next phase of its multi-stage transformation initiative, and to provide preliminary unaudited 2025 results, 2026 guidance...

Short Interest in Evotec AG (NASDAQ:EVO) Grows By 36.3%

Evotec AG (NASDAQ:EVO - Get Free Report) was the recipient of a large increase in short interest in February. As of February 27th, there was short interest totaling 352,335 shares, an increase of...

Evotec (NASDAQ:EVO) Shares Gap Down - Here's Why

Evotec (NASDAQ:EVO) Shares Gap Down - Time to Sell...

Evotec (NASDAQ:EVO) Reaches New 1-Year Low - Should You Sell?

Evotec (NASDAQ:EVO) Sets New 12-Month Low - Here's What Happened...

Evotec AG (NASDAQ:EVO) Receives Consensus Rating of "Hold" from Brokerages

Shares of Evotec AG (NASDAQ:EVO - Get Free Report) have earned a consensus rating of "Hold" from the five research firms that are presently covering the stock, Marketbeat.com reports. One equities...

Evotec (NASDAQ:EVO) Sees Large Volume Increase - Should You Buy?

Evotec (NASDAQ:EVO) Sees Large Volume Increase - Time to Buy...

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

Evotec SE - ADR

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$2.59
Prev Close	$2.54
Open	$2.54
Dividend Yield	N/A
50-Day Moving Average	$3.11
Beta	1.03
Avg. Volume	133,617.17
PE Ratio	-5.21

52-Week High	$4.80
52-Week Low	$2.31
Market Capitalization	$920.54M
EPS (Annual)	N/A
Price to Book	0.98
Revenue Per Employee	N/A

EVO
Eaton Vance Ohio Municipal Income Trust

Feed

News

Sentiment

Fundamentals

Info

Latest EVO News

EVOEaton Vance Ohio Municipal Income Trust